Peter Bartenstein

21.3k total citations · 2 hit papers
400 papers, 12.7k citations indexed

About

Peter Bartenstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peter Bartenstein has authored 400 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Radiology, Nuclear Medicine and Imaging, 96 papers in Pulmonary and Respiratory Medicine and 65 papers in Oncology. Recurrent topics in Peter Bartenstein's work include Medical Imaging Techniques and Applications (85 papers), Radiopharmaceutical Chemistry and Applications (58 papers) and Glioma Diagnosis and Treatment (46 papers). Peter Bartenstein is often cited by papers focused on Medical Imaging Techniques and Applications (85 papers), Radiopharmaceutical Chemistry and Applications (58 papers) and Glioma Diagnosis and Treatment (46 papers). Peter Bartenstein collaborates with scholars based in Germany, Switzerland and Austria. Peter Bartenstein's co-authors include Axel Rominger, Wolfgang P. Fendler, Nathalie L. Albert, Harun Ilhan, Vera Wenter, Marcus Hacker, Christian la Fougère, Marcus Unterrainer, Matthias Brendel and Christian G. Stief and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Peter Bartenstein

396 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

2011 434 citations Peter Bartenstein, Katharina Büerger et al. profile →
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

2019 240 citations Jens Ricke, Peter Bartenstein et al. profile →

Peers

Countries citing papers authored by Peter Bartenstein

Since Specialization

Citations

This map shows the geographic impact of Peter Bartenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bartenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bartenstein more than expected).

Fields of papers citing papers by Peter Bartenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bartenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bartenstein. The network helps show where Peter Bartenstein may publish in the future.

Co-authorship network of co-authors of Peter Bartenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bartenstein. A scholar is included among the top collaborators of Peter Bartenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bartenstein. Peter Bartenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphatic drainage of sinonasal malignancies and the role of sentinel node biopsies 2024 ·Orphanet Journal of Rare Diseases ·(unknown), (unknown), Peter Bartenstein, Michel Canis, Frank Haubner	1
2	Functional maturation and longitudinal imaging of intraportal neonatal porcine islet grafts in genetically diabetic pigs 2024 ·American Journal of Transplantation ·(unknown), (unknown), (unknown), (unknown), Daniel Puhr‐Westerheide, (unknown), Clemens C. Cyran, Max Seidensticker, Richard Lindner, (unknown), Simone Renner, Daphne Merkus, Daniel Teupser, Peter Bartenstein, Sibylle Ziegler, Eckhard Wolf, Elisabeth Kemter	2
3	Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy 2024 ·NeuroImage ·(unknown), Johannes Gnörich, Karin Wind, (unknown), Artem Zatcepin, Thomas Wiedemann, (unknown), Simon Lindner, Guido Boening, Barbara von Ungern‐Sternberg, Leonie Beyer, Jochen Herms, Peter Bartenstein, Matthias Brendel, Florian Eckenweber	2
4	Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS 2023 ·EJNMMI Physics ·(unknown), Wei Bo Li, Simon Lindner, (unknown), (unknown), Peter Bartenstein, Sibylle Ziegler, Guido Böning, (unknown)	7
5	Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging 2023 ·NeuroImage Clinical ·(unknown), (unknown), (unknown), Nils Briel, Karin Wind, (unknown), Lea H. Kunze, Johannes Gnörich, Simon Lindner, Franz‐Josef Gildehaus, Karlheinz Baumann, Peter Bartenstein, Guido Boening, Sibylle Ziegler, Johannes Levin, Andreas Zwergal, Günter U. Höglinger, Jochen Herms, Matthias Brendel	2
6	Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals 2021 ·Pharmaceuticals ·(unknown), (unknown), (unknown), (unknown), (unknown), Carmen Wängler, Peter Bartenstein, Leonie Beyer, Simon Lindner, Klaus Jurkschat, Björn Wängler, Justin J. Bailey, Ralf Schirrmacher	17
7	Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images 2020 ·Annals of Nuclear Medicine ·Kazunari Ishii, Takahiro Yamada, Kohei Hanaoka, Hayato Kaida, Koichi Miyazaki, Masami Ueda, (unknown), Kazumasa Saigoh, Julia Sauerbeck, Axel Rominger, Peter Bartenstein, Yuichi Kimura	5
8	Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Vera Wenter, (unknown), Marcus Unterrainer, (unknown), Sebastian Lehner, Nathalie L. Albert, Peter Bartenstein, Thomas Knösel, Christine Spitzweg, Harun Ilhan, Andrei Todica	13
9	Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease 2019 ·NeuroImage Clinical ·Leonie Beyer, (unknown), Philipp M. Kazmierczak, Michael Ewers, Sonja Schönecker, Catharina Prix, (unknown), Marcus Unterrainer, Cihan Catak, Oliver Pogarell, Robert Perneczky, Nathalie L. Albert, Peter Bartenstein, Adrian Danek, Katharina Büerger, Johannes Levin, Axel Rominger, Matthias Brendel	10
10	The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients 2018 ·Annals of Nuclear Medicine ·Julia Sauerbeck, Kazunari Ishii, (unknown), Hayato Kaida, (unknown), Kohei Hanaoka, Axel Rominger, Matthias Brendel, Peter Bartenstein, Takamichi Murakami	6
11	Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT 2018 ·Cancer Imaging ·Wolfgang G. Kunz, (unknown), Robert Stahl, Philipp M. Kazmierczak, Peter Bartenstein, Axel Rominger, Christoph J. Auernhammer, Christine Spitzweg, Jens Ricke, Clemens C. Cyran	17
12	Impact of ⁶⁸Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis 2018 ·Journal of Nuclear Medicine ·Nina-Sophie Schmidt-Hegemann, Chukwuka Eze, Minglun Li, Paul Rogowski, Christian Schaefer, Christian G. Stief, Alexander Büchner, Constantinos Zamboglou, Wolfgang P. Fendler, Ute Ganswindt, Clemens C. Cyran, Peter Bartenstein, Claus Belka, Harun Ilhan	39
13	The FTD ‐like syndrome causing TREM 2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism 2017 ·The EMBO Journal ·Gernot Kleinberger, Matthias Brendel, Éva Mracskó, Benedikt Wefers, (unknown), Xianyuan Xiang, Carola Focke, Maximilian Deußing, Marc Suárez‐Calvet, Fargol Mazaheri, Samira Parhizkar, (unknown), Wolfgang Wurst, Regina Feederle, Peter Bartenstein, Thomas Mueggler, Thomas Arzberger, Irène Knuesel, Axel Rominger, Christian Haass	144
14	Positronenemissionstomographie 2013 in Deutschland: Ergebnisse der erhebung und standortbestimmung 2015 ·Nuklearmedizin - NuclearMedicine ·J. Kotzerke, Liane Oehme, Oliver Lindner, D. Hellwig, Peter Bartenstein, R. P. Baum, Wolfgang Burchert, Markus Dietlein, Uwe Haberkorn, Regine Kluge, Wolfram H. Knapp, Torsten Kuwert, Egbert Nitzsche, S. N. Reske, P. Reuland, H Schicha, Otmar Schober, Markus Schwaiger, Joerg van den Hoff	2
15	Impact of 68Ga-DOTATATE PET/CT on the Surgical Management of Primary Neuroendocrine Tumors of the Pancreas or Ileum 2014 ·Annals of Surgical Oncology ·Harun Ilhan, Wolfgang P. Fendler, Clemens C. Cyran, Christine Spitzweg, Christoph J. Auernhammer, Franz‐Josef Gildehaus, Peter Bartenstein, Martin K. Angele, Alexander Haug	37
16	High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal 2013 ·Thyroid ·Peter Bartenstein, (unknown), C.L. Maini, Renzo Mazzarotto, (unknown), T. Petrich, Fernando Rodrigues, Juan Antonio Vallejo Casas, Federica Vianello, Michela Basso, (unknown), Alexander Haug, (unknown), (unknown), Rosa Sciuto, James A. Magner	23
17	FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status 2012 ·Radiotherapy and Oncology ·Maximilian Niyazi, Oliver Schnell, Bogdana Suchorska, Silke Birgit Schwarz, Ute Ganswindt, Julia Geisler, Peter Bartenstein, Friedrich-Wilhelm Kreth, Jörg‐Christian Tonn, Sabina Eigenbrod, Claus Belka, Christian la Fougère	42
18	Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay 2011 ·Biological Psychiatry ·Stefan Förster, Timo Grimmer, Isabelle Miederer, Gjermund Henriksen, Behrooz H. Yousefi, (unknown), Hans‐Jürgen Wester, Hans Förstl, Alexander Kurz, Bradford C. Dickerson, Peter Bartenstein, Alexander Drzezga	75
19	Influence of Cell Proportions and Proliferation Rates on FDG Uptake in Squamous-Cell Esophageal Carcinoma: A PET Study 2007 ·Cancer Biotherapy and Radiopharmaceuticals ·Inga Buchmann, Uwe Haberkorn, Irene Schmidtmann, Christoph Brochhausen, Hans‐Georg Buchholz, Peter Bartenstein, Torsten Hansen	9
20	Automatical registration of brain volume datasets 1995 ·MPG.PuRe (Max Planck Society) ·Frithjof Kruggel, Peter Bartenstein	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact